I'm with you POS. After the positive Rett results I never thought this SP territory would be revisited. There isn't even a bad trial result to cause it to drop it back nearly 50%. Plus there are 3 further top line results in 2nd half 2015.
The churning of these converted options is creating some brilliant buying opportunities leading up to the next run of results.
Ann: Annual Report to shareholders, page-25
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$23.01 |
Change
2.300(11.1%) |
Mkt cap ! $2.919B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $23.16 | $21.60 | $18.92M | 836.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 377 | $22.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.01 | 25 | 2 |
View Market Depth
| Last trade - 14.46pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$23.26 |
Change
2.300 ( 12.4 %) |
||||
| Open | High | Low | Volume | ||
| $22.98 | $23.32 | $21.60 | 257865 | ||
| Last updated 15.03pm 27/05/2024 ? | |||||
| NEU (ASX) Chart |